Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-03-24
2011-11-22
Solola, Taofiq A (Department: 1622)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C585S351000
Reexamination Certificate
active
08063101
ABSTRACT:
The presently described embodiments are directed to compositions that include one or more carotenoid analogs or derivatives for use in the treatment of a disorder associated with platelet aggregation. Certain embodiments provide for the use of said carotenoid analogs or derivatives in preparing compositions suitable for use in such treatments. Further embodiments provide for pharmaceutical compositions that include one or more carotenoid analogs or derivatives in combination with one or more additional compositions or medicaments suitable for the treatment of a disorder associated with platelet aggregation. Yet further embodiments provide for methods of treating a disorder associated with platelet aggregation that include administering to a subject who would benefit from such treatment pharmaceutical compositions suitable for inhibiting platelet aggregation in a subject undergoing said treatments, and that include carotenoid analogs or derivatives, optionally in combination with one or more additional antiplatelet agents.
REFERENCES:
patent: 2768198 (1956-10-01), Marbet
patent: 3206316 (1965-09-01), Klaui
patent: 3788468 (1974-01-01), Gainer
patent: 3853993 (1974-12-01), Gainer
patent: 3975445 (1976-08-01), Kienzle et al.
patent: 4156090 (1979-05-01), Kienzle
patent: 4851339 (1989-07-01), Hills
patent: 5605699 (1997-02-01), Bernhard et al.
patent: 6271408 (2001-08-01), Pfander et al.
patent: 6540654 (2003-04-01), Levy et al.
patent: 2002/0051998 (2002-05-01), Schmidt-Dannert et al.
patent: 2002/0169334 (2002-11-01), Levy et al.
patent: 2003/0100045 (2003-05-01), Cheng et al.
patent: 2003/0182687 (2003-09-01), Cheng et al.
patent: 2004/0110849 (2004-06-01), Zelkha et al.
patent: 2006/0058269 (2006-03-01), Lockwood et al.
patent: 2006/0088904 (2006-04-01), Lockwood et al.
patent: 2006/0088905 (2006-04-01), Lockwood et al.
patent: 2006/0111580 (2006-05-01), Lockwood et al.
patent: 2006/0155150 (2006-07-01), Lockwood et al.
patent: 2006/0167319 (2006-07-01), Lockwood et al.
patent: 2006/0178538 (2006-08-01), Lockwood et al.
patent: 2006/0183185 (2006-08-01), Lockwood et al.
patent: 2006/0183947 (2006-08-01), Lockwood et al.
patent: 19950327 (2000-04-01), None
patent: 0542632 (1993-05-01), None
patent: 2000-143688 (2000-05-01), None
patent: WO 96/40092 (1996-12-01), None
Foss et al. “Natural Occurrence of Enantiomeric and Meso Astaxanthin. 7. Crustaceans Including Zooplankton” Comp. Biochem. Physiol. B Comp. Biochem. (1987) 86: 313-314.
Fuhrhop et al. “Bolaform Amphiphiles with a Rigid Hydrophobic Bixin Core in Surface Monolayers and Lipid Membranes” Langmuir (1990) 6, 497-505.
Gabrielska et al. “Zeaxanthin (dihydroxy-B-carotene) but not B-Carotene Rigidifies Lipid Membranres: a 1H-NMR Study of Carotenoid-Egg Phosphatidylcholine Liposomes” Biochim. Biophys. Acta (1996) 1285, 167.
Gartner et al. “Preferential Increase in Chylomicron Levels of the Xanthophylls Lutein and Zeaxanthin Compared to B-Carotene in the Human” Int. J. Vitam. Nutr. Res. (1996) 66, 119.
Furr et al. “Intestinal Absorption and Tissue Distribution of Carotenoids” Nutritional Biochemistry (1997) 8, 364.
Gartner et al. “Lycopene is More Bioavailable from Tomato Paste than from Fresh Tomatoes.” Am. J. Clin. Nutr. (1997) 66: 116-122.
Clark et al. “A Comparison of Lycopene and Astaxanthin Absorption From Corn Oil and Olive Oil Emulsions” Lipids (2000) 35(7), 803-806.
Frank et al. “Effect of the Solvent Environment on the Spectroscopic Properties and Dynamics of the Lowest Excited States of Carotenoids” J. Phys. Chem. B (2000) 104 , 4569-4577.
Bodor et al.“Drug Targeting by Retrometabolic Design: Soft Drugs and Chemical Delivery Systems” J. Recept. Signal Transduct. Res. (2001) 21: 287-310.
Buchwald et al. “Physicochemical Aspects of the Enzymatic Hydrolysis of Carboxylic Esters.” Phamiazie (2002) 57 (2), 87-93.
Zechmeister “Cis-Trans Isomerization and Stereochemistry of Carotenoids and Diphenylpolyenes” Chem. Rev. 34 (1944) 267-344.
Karrer et al. in “Carotenoids, Special Part: XIII. Carotenoid Carboxylic Acids 1. Bixin” Elsevier, New York—Amsterdam—London—Brussels (1950) 256-271.
Robinson “Lysolecithin” Pharm. Pharmacol. (1961) 13, 321.
Markham et al. “Carotenoids of Higher Plants I. The Structures of Lycoxanthin and Lycophyll” Phytochemistry (1968) 7, 839.
Isler in “Carotenoids” Isler, O., Ed.; Birkhäuser: Basel, 1971; 11-28.
Kelly et al. “Carotenoids of Higher Plants. 4. The Stereochemistry of Lycoxanthin and Lycophyll” Chem. Scand., Ser. A (1971) 25, 1607.
Weedon In Carotenoids; Isler, O., Ed.; Birkhäuser: Basel, 1971; pp. 29-59.
Pfander et al. “Synthese von neuen Carotinoid-Glycosylestern” Chimia (1980) 34, 20.
Lindig et al. “Rate Parameters for the Quenching of Singlet Oxygen by Water-Soluble and Lipid-Soluble Substrates in Aqueous and Micellar Systems” Photochem. Photobiol. (1981) 33, 627.
Hertzberg et al. “Carotenoid sulfates. 4. Synthesis and Properties of Carotenoid Sulfates” Acta Chemica Scandinavica B (1985) 39, 629-638.
Milon et al. “Organization of Carotenoid-Phospholipid Bilayer Systems. Incorporation of Zeaxanthin, Astaxanthin, and their C50 Homologues into Dimyristoylphosphatidylcholine Vesicles” HeIv. Chim. Acta (1986) 69:12-24.
Di Mascio et al. “Lycopene as the Most Efficient Biological Carotenoid Singlet Oxygen Quencher” Arch. Biochem. Biophys. (1989) 274 , 532.
Torrissen et al. “Pigmentation of Salmonids—Carotenoid Deposition and Metabolism” CRC Crit. Rev. Aquat. Sci. (1989) 1: 209-225.
Lee et al. “Effects, Quenching Mechanisms, and Kinetics of Carotenoids in Chlorophyll-Sensitized Photooxidation of Soybean Oil” J. Agric. Food Chem. (1990) 38, 1630.
Speranza et al. “Interaction Between Singlet Oxygen and Biologically Active Compounds in Aqueous Solution. III. Physical and Chemical Singlet Oxygen Quenching Rate Constants of 6,6-diapocarotenoids.” (1990) J. Photochem. Photobiol. B8, 51-61.
Mathews-Roth “Recent Progress in the Medical Applications of Carotenoids” Pure Appl. Chem (1991) 63, 147-156.
Beecher et al. “Qualitative Relationship of Dietary and Plasma Carotenoids in Human Beings” Ann NY Acad Sci (1992) 669: 320-321.
Devasagayam et al. “Synthetic Carotenoids, Novel Polyene Polyketones and New Capsorubin Isomers as Efficient Quenchers of Singlet Molecular Oxygen” Photochem. Photobiol. (1992) 55:511-514.
Khachik et al. “Separation and Quantification of Carotenoids in Human Plasma” in “Carotenoids. Part A. Chemistry, separation, quantitation, and antioxidation” Packer L , editor.; San Diego: Academic Press, Inc., (1992) 205-219.
Ames et al. “DNA Lesions, Inducible DNA Repair, and Cell Division: Three Key Factors in Mutagenesis and Carcinogenesis” Environ Health Perspect (1993) 101 (Suppl. 5): 35-44.
Blanchard-Desce et al. “Caroviologens. Synthesis and Optical Properties of A,O-bis-Pyridine and A-O-bis-Pyridinium Polyenes” Bull. Soc. Chim. Fr. (1993) 130, 266-272.
Jyonouchi et al. “Studies of Immunomodulating Actions of Carotenoids. II. Astaxanthin Enhances in vitro Antibody Production to T-dependent Antigens without Facilitating Polyclonal B-cell Activation” Nutr. Cancer (1993) 19, 269-280.
Hirayama et al. “Singlet Oxygen Quenchiing Ability of Naturally Occurring Carotenes” Lipids (1994) 29, 149.
Koga et al. “Synthesis of Phosphatidyl Derivative of Vitamin E and its Antioxidant Activity in Phospholipid Bilayers” Lipids (1994) 29, 83.
Olson “Absorption, Transport, and Metabolism of Carotenoids in Humans” Pure & Applied Chemistry (1994) 66, 1011.
Jyonouchi et al. “Astaxanthin, a Carotenoid Without Vitamin A Activity, Augments Antibody Responses in Cultures Including T
Lockwood Samuel F.
Mason R. Preston
Cardax Pharmaceuticals, Inc.
Meyertons Eric B.
Meyertons Hood Kivlin Kowert & Goetzel P.C.
Solola Taofiq A
LandOfFree
Carotenoid analogs and derivatives for the prevention of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Carotenoid analogs and derivatives for the prevention of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carotenoid analogs and derivatives for the prevention of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4278744